Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
472 trades
$10.3T in total
Open-market sales
925 trades
$1.1B in total
Insiders filing
420 insiders
Last 7 days
Trade type
ProMIS NeurosciencesPMN
Open-market buy04/2204/234,000 sh$11.33$45,320+612.6%
ProMIS NeurosciencesPMN
Open-market buy03/0503/062,000 sh$24.40$48,800+19.2%
Director
ProMIS NeurosciencesPMN
Open-market buy03/02–03/0403/044,000 sh3 trades$23.11avg.$92,420+62.5%
Johanne KaplanChief Development Officer
ProMIS NeurosciencesPMN
Open-market buy02/1902/231,629 sh$15.35$25,005.15+70.5%
ProMIS NeurosciencesPMN
Open-market buy02/0302/05700,741 sh$12.13$8,499,988.33+289.1%
ProMIS NeurosciencesPMN
Open-market buy25/10/0325/10/0630,392 sh$0.49$14,892.08+202.7%
ProMIS NeurosciencesPMN
Open-market sale25/06/3025/07/0293,223 shIn footnoteNo stated value−100.0%
Neil CashmanChief Scientific Officer
ProMIS NeurosciencesPMN
Open-market buy25/02/1025/02/1215,000 sh$0.97$14,550+927.6%
Director
ProMIS NeurosciencesPMN
Open-market buy24/09/20–24/09/2424/09/24200,000 sh3 trades$1.28avg.$255,600+2400.1%
10% Owner
ProMIS NeurosciencesPMN
Open-market buy24/09/16–24/09/1724/09/1893,223 sh2 trades$1.25avg.$116,664.62No record
ProMIS NeurosciencesPMN
Open-market buy24/08/1424/08/1610,000 sh$1.25$12,500+18.9%
ProMIS NeurosciencesPMN
Open-market buy24/07/3124/08/02465,116 shIn footnoteNo stated value+41.9%
ProMIS NeurosciencesPMN
Open-market buy24/07/3124/08/02697,674 shIn footnoteNo stated value+90.6%
ProMIS NeurosciencesPMN
Open-market buy24/07/3124/08/02465,116 shIn footnoteNo stated value+41.9%